Last update 01 Nov 2024
Shanghai Jiabao Yaoyin Pharmaceutical Technology Co., Ltd.
Private Company|
2021|
Shanghai Shi, China
Last update 01 Nov 2024
Overview
Tags
Neoplasms
Nervous System Diseases
Immune System Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
评价JDB153单药治疗晚期实体瘤患者安全性、有效性及药代动力学特征的开放、单中心、I期临床研究
[Translation] An open, single-center, phase I clinical study to evaluate the safety, efficacy, and pharmacokinetic characteristics of JDB153 monotherapy in patients with advanced solid tumors
评价JDB153片在中国健康成人受试者中的随机、两周期、双交叉食物影响研究
[Translation] A randomized, two-period, double-crossover food-effect study evaluating JDB153 tablets in healthy Chinese adult subjects
评价JDB175单药治疗复发或难治性弥漫性大B细胞淋巴瘤患者安全性、耐受性、药代动力学特征及初步有效性的开放、多中心、I期临床研究
[Translation] An open, multicenter, phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of JDB175 monotherapy in patients with relapsed or refractory diffuse large B-cell lymphoma
100 Clinical Results associated with Shanghai Jiabao Yaoyin Pharmaceutical Technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai Jiabao Yaoyin Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Jiabao Yaoyin Pharmaceutical Technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 26 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
2
Phase 1 Clinical
Phase 2 Clinical
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free